The effect of endotoxin shock on blood zinc levels and plasma protein concentrations / by Gunter, Bobby J.
This dissertation has been —
microfilmed exactly as received 6 7-9949
GUNTER, Bobby Jack, 1941- 
THE EFFECT OF ENDOTOXIN SHOCK ON BLOOD ZINC 
LEVELS AND PLASMA PROTEIN CONCENTRATIONS.
The University of Oklahoma, Ph.D., 1967 
Philosophy
University Microfilms, Inc., Ann Arbor, Michigan
THE UNIVERSITY OF OKLAHOMA 
GRADUATE COLLEGE
THE EFFECT OF ENDOTOXIN SHOCK ON BLOOD ZINC LEVELS 
AND PLASMA PROTEIN CONCENTRATIONS
A DISSERTATION 
SUBMITTED TO THE GRADUATE FACULTY 
in partial fulfillment of the requirements for the
degree of 
DOCTOR OF PHILOSOPHY
BY
BOBBY Jt GUNTER
Oklahoma City, Oklahoma 
1967
THE EFFECT OF ENDOTOXIN SHOCK ON BLOOD ZINC LEVELS 
AND PLASMA PROTEIN CONCENTRATIONS
APPROVECnBY
DISSERTATION COMMITTEE
ACKNOWLEDGMENTS
I wish to express my appreciation to Dr. Carl A. Nau, Dr. Lerner 
B. Hinshaw, Dr. Charles H. Lawrence, Dr. Leon S. Ciereszko, and Dr. John 
B. Bruce for serving on my graduate committee.
Special appreciation is given to Dr. Lerner B. Hinshaw and Dr. 
Charles H. Lawrence who contributed their time, knowledge and experience 
as committee members.
Individual consideration is extended to Lura A. Solomon, Phys­
iology graduate student, and Edgar L. Lichti, Preventive Medicine and 
Public Health graduate student.
The author would like to express appreciation to Mrs. Madeline 
Farmer for typing this manuscript, and to Dr. Robert N. Thompson for 
technical drawings.
This investigation was supported by USPHS Training Grants No. 
EH-66-635 and HE-09381.
Ill
TABLE OF CONTENTS
Page
LIST OF TABLES.................................................  v
LIST OF FIGURES................................................  vii
Chapter
I. INTRODUCTION ............................................ 1
II. LITERATURE REVIEW......................................  4
III. PURPOSE AND SCOPE......................................  15
IV. EXPERIMENTAL EQUIPMENT.........  17
V. EXPERIMENTAL PROCEDURE .................................. 26
VI. RESULTS................................................  31
VII. DISCUSSION .............................................  41
VIII. SUMMARY AND CONCLUSIONS................................. 45
REFERENCES ..................................................... 47
APPENDIX....................................................... 51
iv
LIST OF TABLES
Table Page
1. The Effect of Endotoxin in the Dog and Monkey............  6
2. Whole Blood Zinc Concentration in Dogs Intra­
venously Injected with 0.4 mg/kg (LD/80) E.
coli Endotoxin.................    52
3. Plasma Zinc Concentration in Dogs Intravenously
Injected with 0.4 mg/kg (LD/SO) E. coli Endotoxin .........  53
4. Hematocrit Values in Dogs, Intravenously Injected
with 0.4 mg/kg (LD/80) E. coli Endotoxin  .............. 54
5. Plasma Proteins in Dogs Intravenously Injected with
0.4 mg/kg (LD/80) E. coli Endotoxin ......................  55
6. Whole Blood Zinc Concentration in Dogs Intravenously 
Injected with 20 mg/kg Indomethacin, Followed by 
Intravenous Injection of 0.4 mg/kg (LD/80) E. coli
Endotoxin .........................................   56
7. Plasma Zinc Concentration in Dogs Intravenously 
Injected with 20 mg/kg Indomethacin, Followed by 
Intravenous Injection of 0.4 mg/kg (LD/80) E. coli
Endotoxin...............................................  57
8. Hematocrit Values in Dogs Intravenously Injected with
20 mg/kg Indomethacin, Followed by Intravenous Injection
of 0.4 mg/kg (LD/80) E. coli Endotoxin .................... 58
9. Plasma Proteins in Dogs Intravenously Injected with 20
mg/kg Indomethacin, Followed by Intravenous Injection
of 0.4 mg/kg (LD/80) E. coli Endotoxin ...............  59
10, Plasma Zinc Concentration in Dogs Intravenously Infused
with 30 mg/kg Aspirin Dissolved in 90 Per Cent Ethyl 
Alcohol, Followed by Intravenous Injection of 0.4 mg/kg 
(LD/80) E. coli Endotoxin ................................  60
list of tables— Continued 
Table Page
11. Hematocrit Values in Dogs Intravenously Infused with 
30 mg/kg Aspirin Dissolved in 90 Per Cent Ethyl 
Alcohol, Followed by Intravenous Injection of 0.4
mg/kg (LD/80) E. coli Endotoxin............................ 61
12. Blood pH in Dogs Intravenously Infused with 30 mg/kg 
Aspirin Dissolved in 90 Per Cent Ethyl Alcohol,
Followed by Intravenous Injection of 0.4 mg/kg (LD/80)
E. coli Endotoxin ....................................    62
13. Plasma Zinc Concentration in Dogs Intravenously Infused 
with 30 mg/kg Aspirin, Dissolved in 90 Per Cent Ethyl
Alcohol ........................................    63
14. Hematocrit Values in Dogs Intravenously Infused with 
30 mg/kg Aspirin, Dissolved in 90 Per Cent Ethyl
Alcohol ...................................   64
15. Blood pH in Dogs Intravenously Infused with 30 mg/kg
Aspirin, Dissolved in 90 Per Cent Ethyl Alcohol ......   65
16. Plasma Zinc Concentration in Dogs Intravenously Infused
with 90 Per Cent Ethanol 0.2 ml/kg Body Weight............ 66
17. Hematocrit Values in Dogs Intravenously Infused with
90 Per Cent Ethanol 0.2 ml/kg Body Weight................. 67
18. Blood pH in Dogs Intravenously Infused with 90 Per
Cent Ethanol 0.2 ml/kg Body Wèight  .............   68
19. Plasma Zinc Concentration in Dogs Intravenously Injected
with E. coli Endotoxin, 0.4 mg/kg Body Weight   ........... 69
20. Hematocrit Values in Dogs Intravenously Injected with
0.4 mg/kg (LD/80) E. coli Endotoxin ....................... 70
21. Blood pH in Dogs Intravenously Injected with 0.4 mg/kg
(LD/80) E. coli Endotoxin ................................  71
VI
LIST OF FIGURES
Figure Page
1. Optical Design of the Jarrell-Ash Ebert Spectograph,
with Photomultiplier and Recorder Attachments ............. 22
2. Multi-pass Optical System Composed of the New Corning
Optics   ............................................... 23
3. Standard Zinc Curve ....................................... 24
4. Plasma Zinc. Dogs Surviving 0.4 mg/kg E. coli
Endotoxin ................................................ 32
5. "Control Dogs" Mean Plasma Zinc Concentrations with 
Standard Errors and Mean Hematocrit Values with
Standard Errors .......    33
6. Electrophoretic Patterns of Dog 1 Pretreated with 
Indomethacin Administered I.V., Followed by I.V.
Injection of E. coli Endotoxin (LDgg) .................... 36
7. Electrophoretic Patterns of Dog 2 Pretreated with 
Indomethacin Administered I.V., Followed by I.V.
Injection of E. coli Endotoxin (LD q q ) .....    37
8. Electrophoretic Patterns of Dog 3 Pretreated with 
Indomethacin Administered I.V., Followed by I.V.
Injection of E. coli Endotoxin (LDgg)  ................. 38
9. Electrophoretic Patterns of Dog 4 Pretreated with 
Indomethacin Administered I.V., Followed by I.V.
Injection of E. coli Endotoxin (LD q q ) .................... 39
10. Schema Illustrating Changes Produced by an I.V.
Injection of an LD/80 E. coli Endotoxin ...............   43
Vll
THE EFFECT OF ENDOTOXIN SHOCK ON BLOOD ZINC LEVELS 
AND PLASMA PROTEIN CONCENTRATIONS
CHAPTER I 
INTRODUCTION
For many years the absorption of gram-negative bacteria into the 
blood stream has been known to produce shock. Therapeutic amelioration 
of gram-negative infections has progressed very little, despite the many 
advances in medical research. Endotoxin, a multimolecular lipopolysac- 
charide, located within the cell wall of gram-negative bacteria is the 
agent responsible for the lethality of such organisms (l).
The coliform group includes all aerobic and facultative anaero­
bic gram-negative nonspore-forming bacilli which ferment lactose with gas 
formation (2). Escherichia coli (E. coli) and other bacteria of the coli­
form group constitute one of the predominating organisms in the intesti­
nal contents of man and animal and are only occasionally found in local­
ities not showing recent fecal pollution (3). As a result of this char­
acteristic, the absence of coliform bacteria has been established as an 
index of sanitation in environmental conditions such as potable water, 
bathing and swimming facilities, restaurant accommodations, and hospital 
care units. . An example of using the presence of coliform organisms as 
an indicator of contamination is demonstrated in the bacteriological ex-
2amination of municipal water supplies; if the examination is positive 
for coliform, contamination is assumed and preventive measures are taken 
to avoid the potential coexisting communicable diseases.
Every individual is exposed to minute quantities of endotoxin 
released from degenerating colon bacilli (E. coli and other coliform or­
ganisms) in the intestinal tract which causes the body to develop minute 
quantities of antibodies (l). When pathological conditions permit large 
amounts of endotoxin to enter the circulatory system, an anaphylactic re­
action occurs, often resulting in severe shock which frequently leads to 
death (l). The association of circulatory failure with severe bacterial 
infections has been recognized for some time. Certain coliform serotypes 
as well as the pathogenic strains which are hemolytic are the cause of 
hemorrhagic septicemia one of the most frequently encountered causes of 
urinary tract infections and epidemic diarrheal diseases encountered in 
. children. According to Gilbert (4), Laennec (1831) described the weak 
heart sounds present in circulatory failure which was caused by acute 
bacterial infections. Development of an infection in a surgical or a 
postoperative wound may be revealed by the appearance of acute circula­
tory failure. Identical circulatory failure may develop suddenly in a 
patient suffering from a severe bacterial infection for a period of sev­
eral weeks or even months. In both situations the toxic reactions pro­
duced by endotoxin released from the degenerating gram-negative bacteria 
may ultimately result in death (4).
The shock state, which occurs in human patients during the course 
of bacterial infections of the blood stream caused by gram-negative micro­
organisms is characterized by acute hypotension and generalized circula-
3tory failure and presents a very serious clinical problem (5). Shock 
produced by gram-negative bacteria was initially regarded as a rare oc­
currence, but clinical reports of more than 200 cases in the past decade 
indicate that this is a relatively common complication in both medical 
and surgical patients. Weil (5) observed death in 138 out of 169 pa­
tients treated for bacteremic shock.
Many hypotheses and postulates have been made concerning the en­
dotoxin reaction in man and other species; however, the underlying mech­
anism has not been discovered. All efforts dedicated to uncovering and 
comprehending this mechanism will be well spent.
CHAPTER II
LITERATURE REVIEW
Mechanisms producing bacteremic shock are constantly under ob­
servation by clinical investigators due to the prevalence of bacterial 
shock associated with surgery, peritonitis, pneumonia, and countless other 
traumatic conditions. Since bacteremic shock is caused by endotoxin re­
leased from degenerating gram-negative bacteria, researchers have at­
tempted to relate the chemical composition of endotoxin to its biological 
activity. According to Nowotny (6), Boivin et al. hydrolyzed E. coli 
with dilute acetic acid and observed the dissociation of a slightly toxic 
phosphorus-containing lipid and a toxic polysaccharide. Brinkley et al. 
(7 ) subjected endotoxin to acid and alkaline hydrolysis then analyzed 
all fractions chemically and biologically and suggested the existence of 
a toxic "T" factor which was neither protein, lipid,nor polysaccharide.
A substance referred to as "Lipid A" which was one-tenth as toxic as the 
original endotoxin has also been obtained from endotoxin treated with 
acid and alkaline hydrolysis (6). The decreased toxicity was attributed 
to loss of lipophilic polysaccharides that give endotoxin its water sol­
uble characteristic and indicated that the entire molecule must be pres­
ent in order for endotoxin to attain its characteristic physiological re­
sponse (6). Ribi et al. (8) found the chloroform soluble fraction of
endotoxin to be much less toxic than the entire "Lipid A" precipitate.
A macromolecular complex, preferably the entire endotoxin molecule, was 
shown by Haskins et al. (9) to be one of the major requirements for endo­
toxin to elicit its characteristic response.
Biochemical, hemodynamic, and pathological complications occur­
ring as a result of experimentally induced endotoxin shock have been ob­
served in a large variety of laboratory animals. The canine response to 
endotoxin appears to be the most popular experimental model. MacLean 
and Weil (lO) were among the first investigators to report the response 
of dog to an intravenous injection of E. coli endotoxin. Their observa­
tions showed a precipitous drop in blood pressure with hemorrhagic le­
sions of the intestine. They suggested that increased resistance to out­
flow through the liver and intestine promoted stasis and loss of blood 
volume which supported the decreased venous return, hypotension, and in­
creased portal pressure reported in their experiments. These observa­
tions were also supported by Weil et al. (il). They intravenously in­
jected dogs with E. coli endotoxin and observed hypotension and increased 
portal vein pressure. Hypotension was produced by a fall in cardiac out­
put without a decrease in peripheral resistance. When cardiac filling 
was kept constant by infusion, the arterial pressure remained constant; 
however, the portal pressure elevation was intensified. Weil suggested 
that localized venous spasm in the hepatic venous system and possibly 
elsewhere produced pooling of large quantities of blood. The total ven­
ous return was thereby critically reduced and a fall in cardiac output 
and arterial pressure was the inevitable end result which accounted for 
the hypotension in endotoxin shock.
Changes produced by endotoxin vary from one species to another 
and these changes are best considered separately by species (4). Hinshaw 
and Brake (12) investigated the hemodynamic effects of lethal injections 
of E. coli endotoxin on the dog and monkey. Their results are summarized 
in Table 1,
/ TABLE 1
THE EFFECT OF ENDOTOXIN IN THE DOG AND MONKEY
Post-endotoxin
Measurement Dog Monkey
Systemic arterial 
pressure
Rapid drop Gradual decline
Cardiac output Decrease Decrease
Venous return Decrease Decrease
Total peripheral 
resistance
Variable;
decrease
Decrease
Portal vein pressure Marked early 
decrease
Negligible decrease
Visceral pooling Extensive Absent
Visceral lesions Extensive Absent or minimal
Foreleg vascular 
resistance
Decrease to 
sustained rise
Decrease, increase
Heart rate Early decrease Variable
Hematocrit Marked increase No change or fall
Plasma hemolysis Extensive Absent
White cell count Marked decrease Marked decrease
Similar post-endotoxin responses of man and monkey have been suggested (12),
7The differences observed in dog and monkey during the post-endotoxin pe­
riod should not be overlooked because of the relative phylogenetic prox­
imity of monkey and man (13). Kuida et al. (14) reported a difference 
in the early hemodynamic effects of endotoxin in the monkey, cat and rab­
bit compared with those which occurred in the dog. One possible explana­
tion of this was the minimum and inconsistent changes in the weight of 
short segments of gut in the monkey, rabbit, and cat combined with the 
slight to moderate increment in portal venous pressure. Another explana­
tion was the markedly lesser degree of pooling which was observed in cat 
venous return experiments as compared to the extensive pooling which oc­
curred in the dog. Complete pathological examination of monkeys, rab­
bits, and cats failed to reveal edema or congestion of the abdominal vis­
cera which occurred in the dog (lO) (ll). Morphologic changes in the 
monkey liver were those of ischemic necrosis while the intestines of 
monkeys, cats, and rabbits were pale suggesting significant ischemia. 
Pulmonary hemorrhage and edema were present in both the monkey and the 
rabbit. The pulmonary hypertensive response in the monkey and rabbit was 
consistently present and, although pulmonary artery pressure increased 
to levels averaging 258 per cent and 159 per cent of control, respective­
ly, this effect was transient and did not appear to be the only factor 
leading to systemic hypotension. These investigators concluded that he­
patic vein constriction with splanchnic pooling and reduced venous re­
turn could not be responsible for the early hypotension in these species 
(14). Although species responses vary, endotoxin caused hypotension in 
all mammalian species studied (4). According to Fine (l5), endotoxin 
shock has detrimental effects on most of the organs in the body. The
8effect of endotoxin shock on kidneys was demonstrated by an abrupt de­
cline in urine secretion. "When arterial blood pressure drops to 80 mm 
Hg or less, severe vasoconstriction of the afferent arterioles develops. 
At this level of blood pressure the kidney receives 1 per cent of the 
cardiac output, whereas in health it receives about 19 per cent. Every 
measurable function performed by the liver is impaired in endotoxin shock; 
the secretion of bile, the conjugation of bilirubin, the clearance of 
bromsulfalein (BSP), the deamination of amino acids, the ability to syn­
thesize plasma protein, fibrinogen, prothrombin and urea, and the conver­
sion of pyruvate to glucose, are all defective (15). The hemodynamic 
findings concerning endotoxin shock in various species provide no evi­
dence for an important effect on myocardial function (l).
At present, isolated and perfused organs of various species are 
under observation by many investigators in an effort to discover the mech­
anisms responsible for endotoxin's ability to produce irreversible shock. 
In the dog, liver and small intestine increased in weight, due to pool­
ing of blood (16). The liver weight tended to return to control levels, 
but the small intestine showed a steady gain in weight, which amounted 
to an average of 377 grams after 1 hour, indicating a significant amount 
of pooling. Lillehi and MacLean (17) indicated that the bowel was the 
prime organ in development of irreversible endotoxin shock in the dog. 
Vick et al. (18) administered endotoxin to eviscerated dogs and found 
that survival time was shortened, which indicated that the intestine pro­
vides a defense mechanism against the detrimental effects ;of endotoxin. 
Hinshaw and Nelson (l9) reported an increase in weight of dog intestine 
after endotoxin injection with an increase in total splanchnic resistance
9and arterial pressure. Hinshaw et al. (20) observed almost opposite 
post-endotoxin responses in the monkey intestine. Isolated sections of 
monkey small intestine were continuously perfused with the animals own 
blood and it was found that the weight of the intestine remained rela­
tively constant and that no marked increase in intestinal arterial pres­
sure was observed. Chien et al. (21), using splenectomized dogs and 
dogs with spleen intact, observed changes in blood volume and its dis­
tribution after an intravenous injection of E. coli endotoxin. The plasma 
volume decreased after endotoxin in dogs with spleens intact. A total 
reduction of plasma volume by an average of 36 per cent was observed 2.5 
hours after treatment with endotoxin. Loss of plasma volume became pro­
gressively greater with time and was significantly larger in dogs that 
died within 200 minutes. Splenectomized dogs did not show a significant 
decrease in plasma volume following endotoxin shock. The total circu­
lating plasma protein concentration decreased in all dogs after endotoxin;
however, a greater decrease was observed in dogs with intact spleens.
51Total red cell volume which was determined with Cr tagged erythrocytes, 
showed a slight increase in dogs with intact spleens and a slight de­
crease in splenectomized dogs. Total blood volumes in dogs with spleens 
intact, decreased progressively, declining to an average value of 73 per 
cent of the control values within 2.5 hours after administration of the 
endotoxin. The slight decrease in total blood volume observed in sple­
nectomized dogs was not significant (21). Chien et al. (22) did not ob­
serve a decrease in red cell volume in dogs that were sympathectomized 
and splenectomized and consequently he suggested that the slight decrease 
in total red cell volume in splenectomized dogs was a result of segues-
10
. tration of red blood cells due to sympathetic vasoconstriction. Emerson 
et al. (23) reported the effect of splanchnic sympathetic denervation on 
survival during endotoxin shock in the dog. Hemodynamic parameters such 
as increased hematocrit, decreased pH, and drop in mean systemic arterial 
pressure were very near the same in adrenalectomized, splenectomized, and 
Intact animals. Splanchnic sympathectomy did not enhance survival during 
endotoxin shock.
Almost every investigator in the field of endotoxin shock has 
created his own definition of shock. White, Handler, and Smith (24) de­
fine shock as circulatory failure resulting from loss of fluid from the 
vascular compartment. Fluid loss may occur by hemorrhage, pooling in 
various organs, or through an increase in capillary permeability. Fluid 
loss is controlled in plasma by plasma proteins whose prime function is 
regulation of osmotic balance between interstitial fluid and plasma. At 
ordinary plasma flow rates, proteins do not,cross the capillaries, but 
when plasma flow falls the diffusion of protein becomes very significant 
(24). Decreased venous return and reduced cardiac output followed by a 
drop in blood pressure are consistent observations during endotoxin shock, 
thus indicating a possible mechanism promoting the decreased plasma pro­
tein concentration observed in dogs during the post-endotoxin shock pe­
riod (lO) (ll) (22). In all shocked states the capillaries appear to be­
come permeable to plasma protein and large volumes of protein and albu­
min rich fluid enter extravascular spaces, thereby reducing both plasma 
protein concentration and blood volume (24). The normal total plasma 
protein concentrations for the human, monkey, and dog are approximately 
7.5, 7.3, and 5.5 g/lOO ml, respectively (24) (25). Post-endotoxin shock
11
responses may be partially caused by an accumulation of plasma protein 
in various organs. This was suggested by Aust et al. (26) who observed 
an accumulation of tagged albumin in the intestinal wall of dogs
during the post-endotoxin shock period. Hinshaw et al. (27) did not ob­
serve a decrease in total plasma protein concentration in dogs within 4 
hours after administering a LD/SO E. coli endotoxin.
Endotoxins possess a wide range of biological activity. They 
can affect structure and function of numerous enzymes, organs, and cells, 
change tissue and blood levels of many enzymes, modify carbohydrate, fat, 
and protein metabolism, raise or lower body temperature and increase or 
decrease resistance to bacterial infection (28). This represents only a 
fraction of the broad spectrum of endotoxin's activity. According to 
Bennett (28) an investigator in almost any biological field is likely to 
obtain a "positive" result if he tries endotoxin in the experimental sys­
tem he is studying.
The relation of specific metallic ions to various disease states 
has been shown to have diagnostic value (29). For example, in the pres­
ence of clinical symptoms, the finding of chloride concentration in sweat 
above 60 mEq/liter or sodium above 70 mEq/liter is consistent with the 
diagnosis of cystic fibrosis (29). A single injection of 0.0001 (ig of 
E. coli endotoxin produced a hypoferremia in rats with maximum decreases 
in plasma iron 8 to 16 hours after injection (30). The recent discovery 
of zinc in many purified enzymes has revealed the diversity of its func­
tion in protein and carbohydrate metabolism (31). Zinc is present in a 
peptidase, a phosphatase, and several dehydrogenases of many species which 
jointly cover the entire evolutionary spectrum (31). The following zinc
12
metalloenzymes have been characterized thus far: carbonic anhydrase,
carboxypeptidase, alcohol dehydrogenase, glutamic acid dehydrogenase, 
muscle lactic dehydrogenase, and kidney alkaline phosphatase (3l). Zinc 
activates a number of enzymes important in the metabolism of protein, 
including arginase, glyclyglycine dipeptidase, dehydropeptidase, tripep­
tidase, carnosinase, histidine deaminase, as well as oxaloacetic carboxyl­
ase, various lecithinases and enolases (31) (32) (33). The total amount 
of zinc in the human body has been estimated to range from 1.3 to 2.3 
grams (34). Apparently no tissue stores zinc preferentially. Injected 
radioactive zinc disappears rapidly from the blood plasma and was concen­
trated initially in the liver, with the liver still containing about 40 
per cent of the injected zinc at the end of several hours. There was con­
siderable and rapid uptake of zinc by the pancreas, kidneys, and pitui­
tary; as the radioactive zinc concentration gradually decreased in these 
organs, it slowly increased in skeletal muscle, skin, hair, red blood 
cells and bones. Attempts have been made to correlate clinical entities 
with either an increase or decrease in blood zinc concentration. An above 
average concentration of zinc was found in patients suffering from hyper­
thyroidism, hypertension, polycythemia, eosinophilia, in patients admin­
istered adrenaline, thyroxine, and in patients receiving X-ray irradia­
tion. Lower than normal levels of plasma zinc have been found in certain 
infections, myocardial infarction, and prenicious anemia. In normal in­
dividuals, patients with polycythemia and most anemias, the erythrocyte 
zinc and carbonic anhydrase activity vary with the hematocrit (34). Wohl 
and Goodhart (35) observed elevated erythrocyte zinc concentration in pa­
tients with sickle cell anemia and pernicious anemia. Decreased serum
13
zinc concentrations have been observed in patients with untreated perni­
cious anemia. The zinc content in leukocytes of patients with various 
chronic and acute leukemias was found to be less than normal and the low­
est values occurred in patients with chronic leukemia and acute lympho­
cytic leukemia. The low erythrocyte zinc levels were not observed when 
a remission was induced by appropriate therapy. The condition of these 
patients was not altered by intravenous injections of zinc (35). The 
normal daily diet of humans contains 10 to 15 milligrams of zinc and the 
normal person excretes from 0.4 to 0.5 mg of zinc in their urine per day; 
however, patients with proteinuria may excrete 2.1 mg of zinc in their 
urine daily.
The potent effects of zinc on growth are recognized and are often 
utilized in animal husbandry. Accelerated growth of pullets, swine, cat­
tle, and other livestock has been demonstrated by adding small amounts 
of zinc to their diets (36) (37) (38). Evidence supporting zinc defi­
ciency in human patients has been published by several investigators. 
Parsad et al. (39) (40) (4l) examined people in Iran and Egypt suffering 
from a syndrome consisting of iron-deficiency anemia, hepatosplenomegaly, 
dwarfism, and hypogonadism. Evidence that these patients were zinc de­
ficient was as follows: the plasma zinc was low, plasma zinc turnover
rate was greater than normal, and the excretion of zinc in stool and 
urine following radioactive zinc administration was less than in control 
subjects. The zinc content in the hair of these dwarfs was low and all 
patients that were studied excreted less zinc in their urines than did 
normal subjects. Addition of zinc to the diets of these patients did not 
appear to improve their clinical symptoms.
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Strain et al. (42) demonstrated zinc accumulation around the 
edge of surgical wounds. The demand for zinc in wound healing has been 
shown indirectly in patients with severe thermal burns. These patients 
showed a striking decrease in hair zinc levels; however, these levels 
progressively increased and reached normal values by the. time the wound 
completely healed. Atherosclerotic patients were found to have low zinc 
levels by Volkov (43), whose patients demonstrated a significant decrease 
in the zinc content of plasma, aorta, liver, myocardium, and pancreas 
with an increased zinc content in the erythrocytes. Macker et al. (44) 
observed values of 67 + 13.8 p.g/lOO ml in patients with acute myocardial 
infarction compared to a normal mean of 120 + 19 [ig/lOO ml for normal 
plasma. Underwood (45) reported a decreased zinc content in malignant 
prostate glands. Vallee (31) states, "it may be predicted safely that 
this element, which plays such a cardinal role in significant aspects of 
metabolism, will be shown to be involved in many other aspects of human 
and animal pathology."
CHAPTER III
PURPOSE AND SCOPE
The literature seems to indicate that extensive work has been 
done in the field of shock produced by E. coli endotoxin. It also indi­
cates that considerable work has been done on zinc alterations associated 
with similar traumatic conditions; however, no attempt has been made by 
previous invetigators to observe the effect of endotoxin shock on zinc 
concentrations in plasma or whole blood. The importance of zinc in the 
hemopoetic system is evidenced by the role of this trace metal in several 
enzyme systems and disease states related to metabolic disorders of the 
blood. For example, metabolic acidosis is known to decrease the activ­
ity of carbonic anhydrase, an enzyme identified as a zinc protein com­
plex, which contains 0.33 per cent zinc as part of its molecule, and is 
responsible for the interconversion of CO2  and H2CO3 (46). Metabolic 
acidosis has also been a consistent observation in patients suffering 
from leukemia, diabetes, and cirrhosis. These patients were observed to 
have lower blood zinc concentrations than normal people (46). It is in­
teresting to note that the pancreas of diabetics contains only one-half 
the normal amount of zinc (46). Because of the importance of zinc in 
the activity of certain enzymes, as mentioned previously, it may be sup­
posed that a zinc deficiency would cause significant biochemical changes
15
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in the metabolism of those substrates affected by the enzymes concerned. 
For example, alcohol, a substrate, whose role in the etiology and exacer­
bation of cirrhosis has not yet been fully explained. Alcohol dehydro­
genase, a zinc activated enzyme, is partially responsible for the detox­
ification of alcohol.
This investigation was performed in an effort to expand and il­
lustrate the importance of increased knowledge and understanding of trace 
metal alterations induced by traumatic conditions, and to investigate the 
biochemical aspects of shock produced by gram-negative microorganisms. 
Specifically the purposes of the present investigation were to observe 
alterations in plasma zinc, total blood zinc, plasma protein, and hema­
tocrit values in dogs intravenously injected with 0.4 mg/kg (LD/80) E. 
coli endotoxin and to observe the effect of indomethacin and acetylsali- 
cylic acid on these parameters during endotoxin shock. The ultimate goal 
of this investigation is to provide a foundation for a diagnostic tool 
utilizing the role of zinc during E. coli endotoxin shock. If the devel­
opment and application of such a diagnostic tool appears to be of little 
usefullness, it must be remembered that 10 years ago few investigators 
comprehended the deleterious effect of 100 i^g/ml sodium in potable water 
when ingested by individuals under a physician's care for medical condi­
tions such as congestive heart failure, chronic renal disease with edema, 
toxemia of pregnancy, cirrhosis with ascites, and hypertension (47).
CHAPTER IV 
EXPERIMENTAL EQUIPMENT 
Introduction
Equipment and laboratory facilities used in this investigation 
were located at the Institute of Environmental Health, Department of Pre­
ventive Medicine and Public Health, and the Veterans Administration Hos­
pital, both located at the University of Oklahoma Medical Center, Okla­
homa City, Oklahoma. The Institute of Environmental Health is concerned 
with chronic health problems provoked by environmental conditions, while 
medical research is the major concern of the research group at the Vet­
erans Administration Hospital. Experimental data was collected at the 
Veterans Hospital and sample analysis was performed at the Institute of 
Environmental Health.
Experimental Animal 
The experimental animals consisted of adult mongrel dogs, weigh­
ing from 10 to. 20 kg each, purchased from Alexander Kennels, Lexington, 
Oklahoma. Before being randomly assigned for experimental use animals 
were checked by the staff veterinarian to eliminate animals having bac­
terial and parasitic infections.
Housing and Eating Facilities 
Animal quarters used throughout this investigation consisted of
17
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concrete cages with galvanized iron doors and stainless steel feeders. 
Since all animals were housed under identical conditions and fed a uni­
form diet composed of Kasco Meal supplied by Purina and Horsemeat and 
Gravy purchased from Hill Dog Food Company, the small amount of uncon­
trolled zinc ingestion resulting from oral contact with the galvanized 
doors was the same for the exposure and the control animals.
Pharmaceutical and Bacterial Preparations 
The following preparations were used independently and conjunc­
tively throughout various phases of this investigation.
E. coli Endotoxin 
This preparation was purchased from Difco, Detroit, Michigan, 
and was made up in the laboratory in 1.0 mg/ml concentration by dissolving 
in distilled water,
Acetylsalicylic Acid (Aspirin)
This reagent was purchased from Merck, Chicago, Illinois, and 
was prepared in our laboratory in 150 mg/ml concentration by dissolving 
in 90 per cent ethanol.
Ethanol, 90 Per Cent U.S.P.N.F. Reagent Quality 
Ethyl alcohol was purchased from U. S. Industrial Chemicals Com­
pany, New York City, New York, and was used as a solvent for aspirin.
Indomethacin (1-p-Chlorobenzoyl)-Methoxy- 
2-Methylindole-3-Acetic Acid)
This pharmaceutical was donated by Merck, West Point, Pennsylva­
nia, and was used in 20 mg/ml concentration.
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Nembutal (Pentobarbital) Sodium Solution 
The anesthetic was purchased from Abbott Inc., North Chicago, 
Illinois, and contained 50 mg/ml.
Heparin Sodium Solution 
This solution was purchased from Oregon Inc., West Orange, New 
Jersey, and contained 1000 USP units of heparin per ml of solution.
Isotonic Saline Solution 
This solution was prepared in our laboratory by dissolving 225 
grams of sodium chloride in 25 liters of distilled water.
Deionized,Water
The water used for all aqueous solutions was prepared in our 
laboratory by passing distilled water through two ion-exchange resin col­
umns. After the preceding treatment the water was analyzed by atomic 
absorption and it was found to be zinc free.
Zinc Reference Solution 
A standard zinc solution, vAich contained 10,000 ppm zinc, was 
purchased from Fisher Scientific Conpany, Fairlawn, New Jersey, and was 
diluted with deionized water to meet our specifications.
Phenol Reagent
This reagent was purchased from Harelco Chemical Company, 
Philadelphia, Pennsylvania, and was used for making protein determinations.
Infusion Apparatus 
A Harvard infusion pump was used throughout this study for ad-
20
ministering various substances. The pump controlled the rate of infus­
ion and eliminated physical impairments such as blood clotting and lung 
damage both of which are consistently observed in animals receiving di­
rect injections of alcohol or aspirin or a mixture of the two.
Sample Collection and Dilution
Blood samples were secured in 10 milliliter quantities and cen­
trifuged at 5,000 X g for 15 minutes following which the plasma was with­
drawn and placed in 10 milliliter test tubes which were sealed with para- 
film and refrigerated until analyzed. Whole blood samples were collected 
in 10 milliliter quantities and frozen until analyzed. All equipment 
used for securing samples and for making the final analyses was checked 
periodically for .zinc contamination. At the time of sample collection 
blood pH and hematocrit ratios were determined. Hematocrit values were 
duplicately determined in capillary tubes centrifuged at 15,000 x g for 
5 minutes and blood pH was determined on an electric, expanded scale 
meter, manufactured by Dallas Radionics.
Several methods have been reported for the determination of zinc 
by atomic absorption; however, it was found that the procedure described 
for serum analyses was not applicable for determining plasma and whole 
blood zinc (29) (39) (48). The technique developed during the present 
investigation involved the dilution of each plasma sample with 5 parts 
deionized water and the dilution of each whole blood sample with 5 parts 
0.12 N HCl. Direct aspiration of these samples into the flame gave accu­
rate and reproducible recovery values and minimized the mechanical diffi­
culties encountered when concentrated vhole blood and plasma were ana­
lyzed.
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Zinc Analysis
A Jarrell-Ash Atomic Absorption Spectrophotometer Model 82-362 
was the instrument used for zinc analysis. This instrument utilized a 
0.5 meter Ebert mount monochromator, a grating of 30,000 lines per inch 
in the ultraviolet range (Figure l) and incorporated a five pass optical 
system (Figure 2) which consisted of Corning optics and permitted almost 
100 per cent transmission of ultraviolet light. The photon source was a 
zinc hollow cathode tube manufactured by Westinghouse and operated at 10 
milliamperes. Sample excitation was provided by a direct aspiration 
Hecto burner using hydrogen at 8 psi and air at 21 psi. An RCA photomul­
tiplier tube Model IR 106 was operated at 900 volts and the analytical 
line used for zinc analysis at maximum sensitivity was 2139 A.
Atomic absorption spectroscopy is a sensitive method for the 
analysis of metals in solution and is based on the capability of atoms 
to absorb radiation of well-defined characteristic wavelengths. When 
resonant radiation is passed through a dense population of neutral atoms 
in a flame, absorption occurs and traversing radiation is diminished.
This intensity decrease of incident radiation is proportional to the con­
centration of absorbing atoms in the flame and thus proportional to the 
concentration in the dissolved material (49). As exemplified in Figure 
3 working curves (Beer's Law Curves) were prepared for each series of 
samples.
Protein Determination
Total plasma proteins were determined by a method described by 
Lowry et al. (50). This method measures the color produced by a combina­
tion of the biuret reaction of protein with copper in alkali and the
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Figure 1. Optical design of the Jarrell-Ash Ebert spectograph, 
with photomultiplier and recorder attachments.
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Figure 2. Multi-pass optical system composed of the new Corning optics.
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Figure 3. Standard zinc curve.
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reduction of phosphomolybdic-phosphotungstic reagent by the tyrosine and 
tryptophan present in the treated protein. The final blue color was mea­
sured on a Beckman DU Spectrophotometer at 500 mp. Protein fractions 
were qualitatively separated by paper electrophoresis and quantitated on 
a Beckman Analytrol which measures the density of the stained electro­
phoretic stripe.
CHAPTER V
EXPERIMENTAL PROCEDURE
A total of 93 animals, divided into two experimental groups, 
were used in this investigation. Animals in one group were observed for 
a maximum of 144 hours unless terminated by death while animals in the 
other group were observed for a maximum of 2 hours.
Survival Animals 
The initial portion of this study evaluated the LD value of the 
endotoxin employed which had been previously established as LD/80 at 0.4 
mg/kg body weight. Twenty-five animals were anesthetized with sodium 
pentobarbital given intravenously, 25 to 35 mg/kg body weight, followed 
by an intravenous injection of E. coli endotoxin, 0.4 mg/kg body weight. 
These intact animals offered an excellent opportunity to observe plaspia 
zinc concentrations before and after endotoxin injection. Blood samples 
were secured for zinc analysis from the .cephalic vein of the left fore­
limb immediately after the animals were anesthetized and before endo­
toxin injection. Additional samples were collected every 24 hours after 
endotoxin injection for a maximum of 144 hours unless interrupted by 
death of the animal. Animals that survived 144 hours were listed as per­
manent survivors. Plasma zinc was the only measurement possible on this 
group. Observing other parameters would have been useful; however,
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circulatory collapse made it difficult to secure sufficient blood sample 
for zinc analysis and in most cases impossible to secure enough sample 
to make additional measurements.
Two control groups were observed throughout this,phase of the 
study. One group was composed of six animals, anesthetized,with sodium 
pentobarbital intravenously, 25 to 35 mg/kg body weight while the other 
group was composed of nine unanesthetized animals. Plasma zinc was mea­
sured on all controls and hematocrits were measured on anesthetized con­
trols.
In the preceding study most of the animals that were given endo­
toxin survived at least 2 but less than 12 hours, therefore the follow­
ing experimental groups were limited to observation periods of 2 hours 
each.
Two-Hour Post-Endotoxin Shock
This group was composed of five animals each anesthetized with 
sodium pentobarbital intravenously, 30 mg/kg body weight, followed by an 
intravenous injection of E. coli endotoxin, 0.4 mg/kg body weight. One 
femoral artery and vein were exposed; the artery was used to measure 
pressure while the vein was used for sampling and administration of endo­
toxin. Plasma zinc, total blood zinc, hematocrit, and total plasma pro­
tein concentrations were measured before endotoxin injection and again 
120 minutes after endotoxin administration. This group showed altera­
tions in all parameters that were observed; therefore, the following 
study was devised to see if aspirin or indomethacin, two anti-inflamma­
tory agents, would effect these changes.
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Indomethacin Therapy 
This experimental group consisted of 12 dogs each subjected to 
indomethacin treatment prior to E. coli endotoxin injection. The animals 
were anesthetized with sodium pentobarbital intravenously, 30 mg/kg body 
weight, then given an intravenous injection of indomethacin, 20 mg/kg 
body weight, followed by an intravenous injection of E. coli endotoxin, 
0.4 mg/kg body weight. One femoral artery and vein were exposed; the 
artery was used to measure pressure vrtiile the vein was used for securing 
blood samples and administering drugs. Blood samples were taken before 
anesthesia and again 120 minutes after endotoxin administration. Plasma 
zinc, total blood zinc, total plasma protein, plasma protein electropho­
retic separations, and hematocrit values were determined on all samples.
Aspirin (Acetylsalicylic Acid) Therapy 
The pharmacological actions of salicylates are complex and ap­
pear to be at least in part, central and part peripheral (51). The an­
algesic action of aspirin is much more effective in relieving skeletal 
pain and headache than visceral pain. The analgesic or anti-nociceptive 
action has generally been^assumed to be central because of an interfer­
ence in the transmission of pain impulses between the hypothalmus and 
the sensory cortex which alters the interpretation of the pain. The anti­
pyretic action of aspirin probably results from an interference with the 
heat regulating centers in the hypothalmus with a resulting dissipation 
of heat by cutaneous vasodilation. The anti-inflammatory reaction of 
aspirin is similar to that of cortisone, aminopyrine, and certain cin- 
chonic acid derivatives whose actions are mostly due to their influence 
on carbohydrate metabolism (51).
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This phase of the investigation involved 36 animals divided in­
to four groups with eight to ten animals in each group. Surgical proced­
ures as described by Hinshaw et al. (52) were followed throughout this 
study. The aspirin employed was dissolved in 90 per cent ethanol and 
contained 150 mg aspirin per milliliter of solution.
Group One
The animals were anesthetized with sodium pentobarbital intra­
venously, 30 mg/kg body weight, followed by an intravenous infusion of 
the aspirin solution, 30 mg/kg body weight, administered at the rate of 
0.33 ml/minute, which was flushed into the animal with an isotonic saline 
flush, administered at the rate of 2.5 ml/minute. Approximately 5 min­
utes after the aspirin was given an intravenous injection of E. coli en­
dotoxin, 0.4 mg/kg body weight was administered. Plasma zinc, pH and 
hematocrit values were determined after the animal had been anesthetized 
and again 120 minutes after endotoxin.
Group Two
The animals were anesthetized with sodium pentobarbital intra­
venously, 30 mg/kg body weight, and given an intravenous infusion of the 
aspirin solution, 30 mg/kg body weight, which was flushed at the rate of 
2.5 ml/minute with an isotonic saline solution. Plasma zinc, pH and he­
matocrit values were determined after the animal had been anesthetized 
and again 120 minutes after aspirin infusion.
Group Three
Animals in this group were anesthetized with sodium pentobar­
bital intravenously, 30 mg/kg body weight, and given an intravenous in-
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fusion of 90 per cent ethanol, 0.2 ml/kg body weight, which was flushed 
at the rate of 2.5 ml/minute with an isotonic saline solution. Plasma 
zinc, pH and hematocrit values were determined after the animal had been 
anesthetized and again 120 minutes after the alcohol infusion.
Group Four
This group was anesthetized with sodium pentobarbital intraven­
ously, 30 mg/kg body weight, and given an intravenous injection of E. 
coli endotoxin, 0.4 mg/kg body weight. Plasma zinc, pH and hematocrit 
values were determined after the animal had been anesthetized and again 
120 minutes after endotoxin injection.
CHAPTER VI
RESULTS
The paired "t” test was used for making a comparative analysis 
of data obtained from animals observed for 2 hours. Mean zinc concen­
trations with the appropriate standard errors were used to compare ani­
mals in the long term "survival" group. Paired observations on the same 
animal minimized the disadvantage of using many varieties of dogs and 
also helped to eliminate any experimental error which could have been 
caused by the difference in the state of health of the dogs.
Long Term "Survival" Observations 
Data from the series of animals employed in this investigation 
are illustrated in Figures 4 and 5. Inspection of this data permits sev­
eral general observations to be made. One of the most interesting is 
that the animal population decreased over 50 per cent within 24 hours 
after administering E. coli endotoxin intravenously, 0.4 mg/kg body 
weight. The calculated LD/sO value of the endotoxin preparation was 
verified by an 80 per cent reduction of our animal population 72 hours 
post-endotoxin injection. Another interesting observation is that the 
plasma zinc concentration decreased from 68 pg/lOO ml the first 24 hoprs 
after endotoxin injection but returned to near pre-endotoxin values at 
the end of 144 hours. The increase in plasma zinc occurring after the
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Figure 5. "Control Dogs" mean plasma zinc concentrations with 
standard errors and mean hematocrit values with standard errors.
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24-hour post-endotoxin period was progressive and appeared to occur as 
the physical appearance of the animal improved. Blood samples were very 
hard to withdraw during this 24-72 hour period. Plasma separated from 
this blood had a yellowish green color indicating the possibility of 
liver dysfunction. The vascular collapse and the metabolic disorder pro­
ducing the yellowish green color had been reversed by the end of 144 
hours.
Figure 5 represents two series of control animals; one group was 
anesthetized with sodium pentobarbital intravenously, 30 mg/kg body 
weight while the other group was not anesthetized. Plasma zinc concen­
trations were nearly the same in all controls and the hematocrit values, 
taken only on anesthetized controls, remained relatively constant through­
out the 144-hour period.
Two-Hour Post-Endotoxin Shock Observations 
Data presented in Tables 2 through 5 (APPENDIX) illustrate changes 
observed 2 hours after an intravenous injection of E. coli endotoxin, 0.4 
mg/kg body weight. Careful examination of the data permits several gen­
eral statements to be made. Significant increases (at a confidence level 
of 95 per cent) were observed in hematocrit values and total blood zinc 
concentration while a significant decrease (at a confidence level of 95 
per cent) was observed in total plasma protein concentration; however, 
changes in plasma zinc were not significant.
Observations Concerning Indomethacin Therapv 
The data from this phase of the investigation are presented in 
Tables 6 through 9 (APPENDIX) and in Figures 6 through 9. Changes were
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observed before and after intravenous injections of indomethacin, 20mg/kg 
body weight, and intravenous injections of E. coli endotoxin, 0.4 mg/kg 
body weight. Significant increases (at a confidence level of 95 per cent) 
were observed in total blood zinc, and hematocrit while a significant de­
crease (at a confidence level of 95 per cent) was observed in total plas­
ma protein concentration. Changes in plasma zinc concentration were not 
significant. Figures 6 through 9 illustrate the decrease in individual 
plasma protein fractions at the end of 2 hours. The albumin fraction de­
creased as shown in Figures 7 and 8. Figures 6 and 9 do not present such 
drastic reductions in albumin but do indicate a more general decrease in 
all plasma protein fractions.
Observations Concerning Aspirin (Acetvlsalicvlic Acid) 
and Ethanol Infusion
Data presented in Tables 10 through 12 (APPENDIX) were collected 
before and after intravenous infusions of acetylsalicylic acid dissolved 
in 90 per cent ethanol, 30 mg/kg body weight, and intravenous injections 
of E. coli endotoxin, 0.4 mg/kg body weight. A study of this data per­
mits limited conclusions to be made. Plasma zinc concentration and pH 
appeared to decrease while the hematocrit values appeared to increase.
None of these changes were significant. The possibility of aspirin and 
alcohol infusion to assist in E. coli endotoxin shock therapy appeared 
to be quite questionable and as a result additional investigations were 
conducted. The results of these successive studies are summarized in the 
following sections.
Aspirin (Acetylsalicylic Acid) and Ethanol 
Infusion Observations
Tables 13 through 15 (APPENDIX) represent data obtained from
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Dog 1: Before Treatment - 59.45 mg/ml
total plasma protein, values represent electrophorsed 
fractions in mg/ml.
^  23.84 5.90 2.97 1.78 24.9G
Dog 1: 2 Hours Post Treatment - 54.55 mg/ml
total plasma protein, values represent electrophoresed 
fractions in mg/ml.
5.59 2.95 24.121.7820.11
Figure 6. Electrophoretic patterns of dog 1 pretreated with in­
domethacin administered I.V., followed by I.V. injection of E. coli endo­
toxin (LDgg).
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Dog 2s Before Treatment - 72.15 mg/ml 
total plasma protein, values represent electro-' 
phoresed fractions in mg/ml.
29.94 91.902.12
Dog 2: 2 Hours Post Treatment - 40.91 mg/ml
total plasma protein, values represent electrophores­
ed fractions in mg/ml
Figure 7s Electrophoretic patterns of dog 2 pretreated with in­
domethacin administered I.V., followed by I.V. injection of E. coli endo­
toxin (LDgg).
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Dog 3: Before Treatment - 55.01 mg/ml
total plasma protein, values represent electro­
phoresed fractions in mg/ml.
1.70G.90 1.00 21.70\1M
Dog 3: 2 Hours Post Treatment - 47.87 mg/ml
total plasma protein, values represent electrophoresed 
fractions in mg/ml.
1 «1 1
18.21 5.20 2.10 2.10 20.30
Figure 8. Electrophoretic patterns of dog3 pretreated with in­
domethacin administered I.V., followed by I.V. injection of E. coli endo­
toxin (LDgg).
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Dog 4: Before Treatment - 56.36 mg/ml
total plasma protein, values represent electro­
phoresed fractions in mg/ml.
3.08 22.321.05 1.07
Dog 4: 2 Hours Post Treatment - 44.82 mg/ml
total plasma protein, values represent electrophoresed 
fractions in mg/ml.
20.62 4.48 2.24 0.1\ 1G.76
Figure 9. Electrophoretic patterns of dog4 pretreated with in­
domethacin administered I.V., followed by I.V. injection of E. coli endo­
toxin (LDgo).
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animals before and after an intravenous infusion of aspirin dissolved in 
90 per cent ethanol, 30 mg/kg body weight. Hematocrit values, pH, and 
plasma zinc concentrations were measured and were found to remain constant 
throughout the experimental group.
Ethanol Infusion Observations 
Tables 16 through 18 (APPENDIX) represent data obtained from an­
imals before and after an intravenous infusion of 90 per cent ethanol,
0.2 ml/kg body weight. Hematocrit values, pH, and plasma zinc concentra­
tions were not altered throughout this experimental group.
E. coli Endotoxin Shock Observations 
Data representing this experimental group may be found in Tables 
19 through 21 (APPENDIX). As in the three preceding groups, these data 
represent measurements taken during the pre- and ppst-endotoxin shock pe­
riods. These animals showed a significant decrease in plasma zinc (at a 
confidence level of 95 per cent) within 120 minutes after E. coli endo­
toxin injection. Changes in pH and hematocrit values were not signifi­
cant.
CHAPTER VII 
DISCUSSION
Alterations observed during the endotoxin reaction consisted of 
decreased plasma zinc and plasma protein concentrations with elevated 
total blood zinc concentration and increased hematocrit values.
Decreased plasma protein concentrations were observed in animals 
receiving a LD/80 E, coli endotoxin, administered intravenously. Liver 
congestion and malfunction, both common during endotoxin shock, appeared 
to be the metabolic disorders producing the decreases in plasma protein 
(10) (ll) (5 4 ). Fine (15) states that even though increased capillary 
permeability exists during the endotoxin shock reaction, significant 
leakage from the capillary bed does not exist, thus, plasma protein de­
creases during endotoxin shock appeared to result from inproper synthe­
sis of such proteins by the liver. Decreased plasma zinc concentrations 
were observed in most of the animals that exhibited decreased plasma pro­
tein concentrations. This observation was expected since 12 to 22 per 
cent of the total blood zinc was bound to the serum albumin and globulin 
fractions (45). Since 75 to 85 per cent of the total blood zinc was 
found in the erythrocytes (34), the increased total blood zinc which was 
accompanied by increased hematocrit values throughout this study was ex­
pected.
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Anti-inflammatory treatment prior to endotoxin injection was in­
cluded in this study. Indomethacin, an anti-inflammatory agent, was in­
travenously injected, 20 mg/kg body weight, then the animal was given an 
intravenous injection of E. coli endotoxin, 0.4 mg/kg body weight. A 
significant decrease in plasma protein concentration and significant in­
creases in total blood zinc concentration and hematocrit values were sim­
ilar to those observed in the animals that received only endotoxin. Hypo­
tension produced by E. colT endotoxin was not altered by indomethacin. 
Based on this study, indomethacin was essentially useless in the therapy 
or prevention of shock produced by E. coli endotoxin.
Aspirin dissolved in 90 per cent ethanol was intravenously in­
fused, 30 mg/kg body weight, then the animal was given an intravenous in­
jection of E. coli endotoxin, 0.4 mg/kg body weight. Plasma zinc, pH, 
and hematocrit values were determined and no significant changes from 
normal were found. Thus, from our observations, it was assumed that as­
pirin should be considered as a potential therapeutic agent for shock 
produced by E. coli endotoxin.
Animals not receiving endotoxin but receiving an intravenous in­
fusion of 90 per cent ethanol, 0.2 ml/kg body weight, and animals intra­
venously infused with aspirin dissolved in 90 per cent ethanol, 30 mg/kg 
body weight, showed no significant alterations in plasma zinc, pH and 
hematocrit values.
Figure 10 is a proposed schema illustrating the biochemical and 
hemodynamic alterations leading to the results reported in this study.
Each of these physiological impairments appears to be partially respon­
sible for the death of the animal. Reduced plasma protein and plasma
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zinc concentrations were consistently accompanied by increased hematocrit 
values and total blood zinc concentrations. A significant alteration in 
one of the four parameters was usually accompanied by significant altera­
tions in the remaining three. The only group of animals deviating from 
the preceding statement were those infused with aspirin prior to endotoxin 
injection. Additional investigation concerning aspirin's potential as a 
therapeutic agent for shock produced by E. coli endotoxin is now in prog­
ress.
CHAPTER VIII 
SUMMARY AND CONCLUSIONS
This investigation was concerned with changes in total blood 
zinc, plasma zinc, hematocrit ratios, pH and total plasma protein concen­
tration resulting from experimentally induced E. coli endotoxin shock,
A total of 93 adult mongrel dogs was divided into two groups; the dogs 
in one group were intravenously injected with E. coli endotoxin (0.4 mg/ 
kg body weight) while those in the other groups received identical treat­
ment preceded by an intravenous injection of indomethacin (20 mg/kg body 
weight) or aspirin (30 mg/kg body weight).
Based on the results of various chemical and biochemical deter­
minations made during this investigation, the following conclusions have 
been drawn:
1. Intravenous administration of E. coli endotoxin, 0.4 mg/kg 
body weight, resulted in a LD/80 for the adult mongrel dogs 
employed in this investigation.
2. An intravenous injection of E. coli endotoxin, 0.4 mg/kg 
body weight produced significant decreases in plasma zinc 
and total plasma protein concentrations and significant in­
creases in the hematocrit values and total blood zinc concen­
trations'.
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3o Indomethacin was observed to have no effect on the altera­
tions in total blood zinc, hematocrit values and total plasma 
protein concentrations induced by an intravenous injection 
of E. coli endotoxin, 0.4 mg/kg body weight.
4. Intravenous infusion of aspirin prior to an intravenous in­
jection of a LD/80 E. coli endotoxin was observed to protect 
the experimental animal from significant changes in pH, 
hematocrit ratios, and plasma zinc concentration.
5. A drastic decrease in plasma zinc concentration occurred 24 
hours after an intravenous injection of E. coli endotoxin,
0.4 mg/kg body weight; however, plasma zinc concentrations 
returned to approximately pre-endotoxin levels in animals 
surviving 144 hours or longer.
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TABLE 2
WHOLE BLOOD ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INJECTED 
WITH 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Zinc pg/lOO ml
-  — L = c a  
X^-Xj (X^-Xg)*
Before treatment 2 hr post-treatment
Xi Xg
192 240 - 48 2,304
162 222 - 60 3,600
264 396 -130 16,900
262 324 - 62 3,844
180 204 - 24 576
ZX 1,060 1,386 -324 27,224
X 212 277.2 - 64.8
/n = 310.45
-d n(n-l)
Sj = 17.61 t = ÏÏ = 65 = 3  
Sj 17.6
.82 , for 4 df
53
TABLE 3
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INJECTED 
WITH 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Zinc pg/lOO ml Xl-%2 (Xl-Xg)^
Before treatment 2 hr post-treatment 
*2
71.00 60.00 11.00 121.00
54.00 46.00 8.00 64.00
61.20 54.00 7.20 51.84
96.00 , 90.00 6.00 36.00
39.00 46.80 - 7.80 60.84
2X 321.20 296.80 24.40 333.68
Y 64.25 59.36 4.88
Sg = 3.27
t = 1.49 for 4 df
54
TABLE 4
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INJECTED WITH 
. 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Hematocrit Xi-x,
Before treatment 
^1
2 hr post-treatment 
X2
33 46 - 13 169
28 34 - 6 36
43 62 - 19 361
42 58 “ 16 256
32 38 - 6 36
2X 178 238 — 60 858
X 35.6 47.6 - 12
sy = 2.62
t = 4.6* for 4 df
55
TABLE 5
PLASMA PROTEINS IN DOGS INTRAVENOUSLY INJECTED 
WITH 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Plasma Proteins
='r>'2
Before treatment 2 hr post-treatment 
%2
55.33 46.85 8.48 71.91
51,65 44.65 7.00 49.00
62.00 60.00 2.00 4.00
65,97 60.95 5.02 25.20
74.40 58.03 16.37 108.16
ZX 307.35 270.48 38.87 258.27
X 61.47 54.10 7.77
Sg- _ 1.46
t = 5.05* for 4 df
56
TABLE 6
WHOLE BLOOD ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INJECTED 
WITH 20 mg/kg INDOMETHACIN, FOLLOWED BY INTRAVENOUS 
INJECTION OF 0.4 mg/kg (LD/BO) E. coli ENDOTOXIN
Zinc ixg/lOO ml X^-X^ (X^-Xg)^
Before treatment 
^1
2 hr post-treatment 
^2
300 364 - 64 4,096
234 252 - 18 324
192 240 - 48 2,304
244 244 0 00
222 264 - 42 1,764
234 264 - 30 900
276 324 - 48 2,304
252 276 - 24 576
252 324 - 72 5,184
180 228 — 48 2,304
264 328 - 64 4,096
300 364 - 64 4,096
2X 2,950 3,472 -522 27,948
X 245.83 289.50 - 43.50
= 6.4
t = 6.79*, for 11 df
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TABLE 7
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INJECTED WITH 
20 mg/kg INDOMETHACIN, FOLLOWED BY INTRAVENOUS INJECTION 
OF 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Zinc pg/lOO ml X1 -X2 (Xl-Xg)^
Before treatment 
%1
2 hr post-treatment 
%2
108.00 69.00 39.00 1,521.00
79.20 90.00 - 10.80 117.00
69.60 55.80 13.80 190.44
69.60 80.00 - 10.40 108.16
71.00 92.00 - 21.00 441.00
60.00 70.80 - 10.80 117.00
70.80 78.00 - 7.20 51.84
70.80 54.00 16.80 282.24
79.60 69.60 10.00 100.00
60.00 70.80 - 10.80 117.00
60.00 61.10 - 1.10 1.21
72.00 62.60 7.40 54.76
2X 870.60 853.70 15.10 3,101.65
X 72.50 71.14 1.26
Sj = 15.2
t = 0.83, for 11 df
58
TABLE 8
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INJECTED WITH 20 mg/kg 
INDOMETHACIN, FOLLOWED BY INTRAVENOUS INJECTION OF 
0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Hematocrit change % (Xj-X2)2
Before treatment 2 hr post-treatment
29.0 44,0 - 15.0 225.00
35.0 32,0 3.0 9.00
33,0 34.0 - 1.0 1.00
39.0 66.5 - 27.5 756.25
38,5 53.0 - 14.5 210.25
35,0 52.0 - 17.0 289.00
35.0 44.0 - 9.0 81.00
35.0 46.0 - 11.0 121.00
30.0 53.0 - 23.0 529.00
37.0 38.0 - 1.0 1.00
31.0 37.0 - 6.0 36.00
36.0 47.0 - 11.0 121.00
413.5 546.5 -133.00 2,379.50
X 34.46 45.54 - 11.10
sg = 2.62
t = 4.19*, for 11 df
59
TABLE 9
PLASMA PROTEINS IN DOGS INTRAVENOUSLY INJECTED WITH 20 mg/kg 
INDOMETHACIN, FOLLOWED BY INTRAVENOUS INJECTION OF 
0.4 mg/kg (LD/80) E. coli ENDOTOXIN
Plasma proteins mg/ml
^-='2
Before treatment 
%1
2 hr post-treatment 
%2
62.41 49.12 15.29 176.62
59.45 55.11 4.34. 18.83
55.01 47.87 7.14 50.98
63.86 49.11 14.75 217.56
58.40 47.03 11.37 129.28
56.36 44.82 11.54 133.17
72.15 40.91 31.24 975.93
68.20 57.21 10.99 120.78
61.12 55.17 15.95 254.40
60.17 49.92 10.25 105.06
62.50 49.57 12.93 167.18
63.14 59.51 3.63 13.17
a  742.77 605.35 147.42 2,362.96
X 61.85 50.44 12.28
= 4.09
t = 3.0*, for 11 df
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TABLE 10
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INFUSED WITH 
30 mg/kg ASPIRIN DISSOLVED IN 90 PER CENT ETHYL ALCOHOL, 
FOLLOWED BY INTRAVENOUS INJECTION OF 
0.4 mg/kg (LD/BO) E. coli 
ENDOTOXIN "
Zinc pg/lOO ml
X1-X2
Before treatment 
%1
2 hr post-treatment 
%2
60.0 60.0 0.0 0.00
37.2 30.0 7.2 51.84
63.0 36.0 27.0 629.00
60.0 60.0 0.0 0.00
64.0 64.0 0.0 0.00
78.0 64.0 14.0 196,00
96.0 96.0 0.0 0.00
54.0 54.0 0.0 0.00
39.0 30.0 9.0 81.00
2X 551.2 494.0 57.2 957.84
X 61.24 56.0 6.35
Sj — 2 o 87
t = 2.21, for 8 çlf
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TABLE 11
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INFUSED WITH 30 mk/kg ASPIRIN 
DISSOLVED IN 90 PER CENT ETHYL ALCOHOL, FOLLOWED BY INTRAVENOUS 
INJECTION OF 0.4 mg/kg (LD/SO) E. coli ENDOTOXIN
Hematocrit change, percentage X,-Xg (Xi-Xg)^
Before treatment 
%1
2 hr fost-treatment 
%2
29.00 33.50 - 4.5 20.25
20.00 24.50 - 4.5 20.25
36.00 38.00 - 2.0 4.00
27.00 26.50 0.5 .25
37,00 37.00 0.0 0.00
38.00 44.00 - 6.0 36.00
31.00 35.00 - 4.0 16.00
35.00 52.00 -17.0 289.00
30.00 28.50 1.5 2.25
SX 283.00 319.00 -36.0 388.00
X 31.44 35.44 4.0
Sy — 1 o 84
t = 2.18, for 8 df
62
TABLE 12
BLOOD pH IN DOGS INTRAVENOUSLY INFUSED WITH 30 rag/kg ASPIRIN DISSOLVED 
IN 90 PER CENT ETHYL ALCOHOL, FOLLOWED BY INTRAVENOUS INJECTION 
OF 0.4 mg/kg (LD/80) E. coli ENDOTOXIN
pH change Xi-x^ <X,-X,)=
Before treatment 2 hr post-treatment 
%2
7.27 7.25 0.02 0.0004
7.32 7.15 0.17 0.0029
7.24 7.22 0,02 0.0004
7.37 7.31 0.06 0.0036
7.33 7.36 - 0.03 0.0009
7.29 7.30 - 0.01 0.0001
7.33 7.34 - 0.01 0.0001
7.27 6.97 0.30 0.0900
7.35 7.30 0.05 0.0025
2X 65.77 65.20 0.57 0.1009
X 7.31 7.24 0.063
= 3.25
a
t = 0.016; for 8 df
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TABLE 13
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INFUSED WITH 30 mg/kg 
ASPIRIN, DISSOLVED IN 90 PER CENT ETHYL ALCOHOL
Zinc ng/lOO ml X1 -X2
Before treatment 
%1
2 hr post-treatment 
%2
64.00 64.00 0.00 0.00
32.40 32.40 0.00 0.00
60.00 45.00 15.00 225.00
63.00 51.60 11.40 129.96
51.60 51.60 0.00 0.00
39.00 27.00 12.00 144.00
39.00 39.00 0.00 0.00
46.80 46.80 0.00 0.00
65.80 65.80 0.00 0.00
SC 461.60 432.20 38.40 498.96
X 52.28 47.02 4.26
s? = 2.15
U
t = 1.981, for 8 df
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TABLE 14
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INFUSED WITH 30 mg/kg 
ASPIRIN, DISSOLVED IN 90 PER CENT ETHYL ALCOHOL
Hematocrit change, percentage Xi-x^ (x,-x^)=
Before treatment 
%1
2 hr post-treatment 
%2
37.00 37.00 0.00 0.00
25.00 24.50 0.50 0.25
36.50 33.00 3.50 12.25
31.00 31.00 0.00 0.00
35.00 34.00 1.00 1.00
30.00 33.00 - 3.00 9.00
35.00 35.00 0.00 0.00
31.00 33.50 - 2.50 6.25
38.00 32.00 6.00 36.00
%  298.50 293.00 5.50 64.75
X 33.16 32.59 0.61
Sÿ = 0o94
t = 0.1, for 8 df
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TABLE 15
BLOOD pH IN DOGS INTRAVENOUSLY INFUSED WITH 30 mg/kg ASPIRIN, 
DISSOLVED IN 90 PER CENT ETHYL ALCOHOL
pH change Xl-%2
(Xl-Xg)^
Before treatment 2 hr post-treatment 
%2
7.12 6.97 0.15 0.0225
7.31 7.40 - 0.09 0.0081
7.29 7.36 - 0.07 0.0049
7.20 7.25 - 0.05 0.0025
7.33 7.37 - 0.04 0.0016
7.35 7.29 0.06 0.0036
7.27 7.35 - 0.08 0.0064
7.29 7.28 0.01 0.0001
7.35 7.38 - 0.03 0.0009
2X 65.51 65.65 - 0.14 0.0506
X 7.28 7.29 0.015
Sj = 0.02588 
t = 0.60, for 8 df
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TABLE 16
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INFUSED WITH 90 
PER CENT ETHANOL 0.2 ml/kg BODY WEIGHT
Zinc }ig/lOO ml
xr%2
Before treatment 
%1
2 hr post-treatment 
%2
62.00 6?. 00 0.00 0.00
99.00 60.00 39.00 1,521.00
79.80 79.80 0.00 0.00
43.00 43.00* 0.00 0.00
60.00 60.00 0.00 0.00
52.00 37.20 14.80 219.04
60.00 49.50 10.50 110.25
39.00 39.00 0.00 0.00
54.00 54.00 0.00 0.00
46.20 46.20 0.00 0.00
2X 595.00 530.70 64.30 1,850.29
X 59.50 53.07 6.43
sj = 4
t = 1.61, for 9 df
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TABLE 17
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INFUSED WITH 90 
PER CENT ETHANOL 0.2 ml/kg BODY WEIGHT
Hematocrit change, percentage
Xl-%2
Before treatment 
%1
2 hr post-treatment 
%2
35.50 32.00 3.5 12.25
40.00 39.00 1.0 1.00
33.00 31.00 2.0 4.00
30.00 28.00 2.0 4.00
33.00 32.00 1.0 1.00
25.50 22.00 3.5 12.25
40.50 38.00 2.5 6.25
31.00 31.00 0.0 0.00
34.50 33.50 0.5 0.25
32.00 35.00 — 3.0 9.00
2X 335.00 321.50 13.0 50.00
X 33.50 32.15 1.3
= 0.5941
t = 2.19, for 9 (if
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TABLE 18
BLOOD pH IN DOGS INTRAVENOUSLY INFUSED WITH 90 PER CENT 
ETHANOL, 0.2 ml/kg BODY WEIGHT
pH change Xi-x^
Before treatment 2 iix post-treatment
7.24 7.30 - 0.06 0.0036
7,31 7.37 - 0.06 0.0036
7.30 7.34 - 0.04 0.0016
7.30 7.31 - 0.01 0.0001
7.35 7.40 - 0.05 0.0025
7.29 7.28 0.01 0.0001
7.38 7.35 0.03 0.0009
7.36 7.35 0.01 0.0001
7.29 7.29 0.00 0.0000
7.32 7.32 0.00 0.0000
2X 73.14 73.31 0.17
1
0.0125
X 7.314 7.331 0.017
=  0.01
t = 1.7, for 9 df
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TABLE 19
PLASMA ZINC CONCENTRATION IN DOGS INTRAVENOUSLY INJECIED WITH
E. coli ENDOTOXIN, 0.4 mg/kg BODY WEIGHT
Zinc (ig/lOO ml X1 -X2 (Xj-X^)^
Before treatment 2 hr post-treatment 
*2
80.00 56.00 24.00 576.00
87.00 84.00 3.00 9.00
52.00 37.00 15.00 225.00
60.00 52.00 8.00 64.00
105.00 96.00 9.00 81.00
108.00 60.00 48.00 2,340.00
60.00 52.00 8.00 64.00
46.00 46.00 0.00 0.00
ZX 598.00 483.00 115.00 3,349.00
X 74.75 60.37 14.37
%  = 5.50 
d
t = 2.67*, for 7 olf
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TABLE 20
HEMATOCRIT VALUES IN DOGS INTRAVENOUSLY INJECIED WITH 
0.4 mg/kg (LD/SO) E. coli ENDOTOXIN
Hematocrit change, percentage X1 -X2 (Xi-Xg)^
Before treatment 
%1
2 hr post-treatment 
%2
32.00 31.00 1.00 1.00
35.00 46.00 - 9.00 81.00
35.00 35.00 0.00 0.00
33.00 32.00 1.00 1.00
35.00 40.00 - 5.00 25.00
28,00 31.00 - 3.00 9.00
30.00 28.50 1.50 2.25
38.00 41.50 - 3.50 12.25
2X 266.00 285.00 -17.0 132.50
X 33.25 35.62 2.12
= 1.31
d
t = 1.62, for 7 df
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TABLE 21
BLOOD pH IN DOGS INTRAVENOUSLY INJECTED WITH 
0.4 mg/kg (LD/BO) E. coli ENDOTOXIN
pH change
Before treatment 
%1
2 hr post-treatment 
%2
7.42 7.17 0.25 0.0625
7.20 7.17 0.03 0.0009
7.34 7.14 0.20 0.0400
7.29 7.19 0.10 0.0100
7.31 7.34 - 0.03 0.0009
7.22 7.24 0.02 0.0004
7.35 6.99 0.36 0.1296
7.29 7.15 0.14 0.0196
7.18 7.15 0.03 0.0009
IX. 66.50 64.54 1.10 0.2648
X 7.38 7.17 0.122
s- = 0.191
t = 0.64, for 8 df
